Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Mroczko

Showing results (161-170 of 291) with videos related to

Pageof 30
Sort By:
Digestive Diseases and Sciences|June 10, 2004
The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitisUrszula Wereszczynska-Siemiatkowska, Barbara Mroczko, Andrzej Siemiatkowski, et al.
Oncotarget|February 6, 2019
Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)Marta Łukaszewicz-Zając, Mariusz Gryko, Sara Pączek, et al.
Clinical Chemistry and Laboratory Medicine|January 25, 2007
Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patientsMagdalena Groblewska, Barbara Mroczko, Urszula Wereszczyńska-Siemiatkowska, et al.
Clinical Chemistry and Laboratory Medicine|July 8, 2010
Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markersMarta Łukaszewicz-Zajac, Barbara Mroczko, Mirosław Kozłowski, et al.
Neurologia I Neurochirurgia Polska|September 21, 2019
Is vitamin D deficiency a reliable risk factor for multiple sclerosis development?Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Monika Chorąży, et al.
Polish Archives of Internal Medicine|July 31, 2018
Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEAAla Litman-Zawadzka, Marta Łukaszewicz-Zając, Mariusz Gryko, et al.
Journal of Clinical Medicine|May 13, 2023
The Clinical Significance of Serum Free Light Chains in Bladder CancerMonika Gudowska-Sawczuk, Jacek Kudelski, Michał Olkowicz, et al.
International Journal of Molecular Sciences|August 12, 2022
Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic CriteriaMaciej Dulewicz, Agnieszka Kulczyńska-Przybik, Piotr Mroczko, et al.
International Journal of Molecular Sciences|August 29, 2024
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological DiseasesKlaudia Kryńska, Katarzyna Kuliś, Wiktoria Mazurek, et al.
Nutrients|May 11, 2024
Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD-A Pilot StudyBeata Zyśk, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka, et al.
Pageof 30

Showing results (161-170 of 291) with videos related to

Sort By:
Pageof 30
Digestive Diseases and Sciences|June 10, 2004
The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitisUrszula Wereszczynska-Siemiatkowska, Barbara Mroczko, Andrzej Siemiatkowski, et al.
Oncotarget|February 6, 2019
Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)Marta Łukaszewicz-Zając, Mariusz Gryko, Sara Pączek, et al.
Clinical Chemistry and Laboratory Medicine|January 25, 2007
Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patientsMagdalena Groblewska, Barbara Mroczko, Urszula Wereszczyńska-Siemiatkowska, et al.
Clinical Chemistry and Laboratory Medicine|July 8, 2010
Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markersMarta Łukaszewicz-Zajac, Barbara Mroczko, Mirosław Kozłowski, et al.
Neurologia I Neurochirurgia Polska|September 21, 2019
Is vitamin D deficiency a reliable risk factor for multiple sclerosis development?Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Monika Chorąży, et al.
Polish Archives of Internal Medicine|July 31, 2018
Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEAAla Litman-Zawadzka, Marta Łukaszewicz-Zając, Mariusz Gryko, et al.
Journal of Clinical Medicine|May 13, 2023
The Clinical Significance of Serum Free Light Chains in Bladder CancerMonika Gudowska-Sawczuk, Jacek Kudelski, Michał Olkowicz, et al.
International Journal of Molecular Sciences|August 12, 2022
Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic CriteriaMaciej Dulewicz, Agnieszka Kulczyńska-Przybik, Piotr Mroczko, et al.
International Journal of Molecular Sciences|August 29, 2024
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological DiseasesKlaudia Kryńska, Katarzyna Kuliś, Wiktoria Mazurek, et al.
Nutrients|May 11, 2024
Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD-A Pilot StudyBeata Zyśk, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka, et al.
Pageof 30